Natalizumab
Le natalizumab est un anticorps anti-4-intégrine humanisé. Il s'agit d'un traitement des formes très actives de sclérose en plaques rémittente-récurrente et il est également utilisé pour les patients atteints de maladie de Crohn.
product
Wikipage redirect
ATC code L04ATC code L04AA23ATCvet code QL04AA23AntegrenBiogenBiological therapy for inflammatory bowel diseaseBoxed warningCrohn's diseaseDrug nomenclatureEugene O. MajorFingolimodHuman polyomavirus 2Interferon beta-1aInterleukin 1 betaJames Mullen (CEO)LifeArcList of drugs: N–NaList of drugs: Trj–TzList of therapeutic monoclonal antibodiesList of withdrawn drugsManagement of Crohn's diseaseManagement of multiple sclerosisMonoclonal antibody therapyMultiple sclerosisMultiple sclerosis drug pipelineOtilimabPathology of multiple sclerosisPerrigoProgressive multifocal leukoencephalopathyRoyalty PharmaTumor microenvironmentTysabriVLA-4Vicki SatoZaurategrastÉlan
Link from a Wikipage to another Wikipage
products
primaryTopic
Natalizumab
Le natalizumab est un anticorps anti-4-intégrine humanisé. Il s'agit d'un traitement des formes très actives de sclérose en plaques rémittente-récurrente et il est également utilisé pour les patients atteints de maladie de Crohn.
has abstract
Le natalizumab est un anticorp ...... atteints de maladie de Crohn.
@fr
Natalizumab (Handelsname Tysab ...... ehört zu den IgG4-Antikörpern.
@de
Natalizumab (commercializzato ...... o in Italia nel dicembre 2006.
@it
Natalizumab (preparaty handlow ...... Unii Europejskiej w 2006 roku.
@pl
Natalizumab es un inhibidor se ...... e la esclerosis múltiple (EM).
@es
Natalizumab is een middel voor ...... ri® en de fabrikant is Biogen.
@nl
Natalizumab je humanizovaná mo ...... falopatie v prevalenci 1:1000.
@cs
Natalizumab é um fármaco utilizado no tratamento da esclerose múltipla.
@pt
Tysabri är ett läkemedel som a ...... hindrar MS från att försämras.
@sv
Натализумаб (англ. natalizumab ...... еренесших имешический инсульт.
@ru
alternative name
Tysabri, Antegren, others
@en
CAS number
189261-10-7
ChEMBL
DrugBank
FDA UNII code
3JB47N2Q2P
KEGG
MedlinePlus
Link from a Wikipage to an external page
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
1,026,219,543
Link from a Wikipage to another Wikipage
ATC prefix
L04
@en
ATC suffix
AA23
@en
bioavailability
n/a
@en
caption
Natalizumab Fab fragment bound to the headpiece of an α4-integrin. From PDB .
@en
CAS number
ChEMBL
ChemSpiderID
none
@en
DailyMedID
Natalizumab
@en
DrugBank
DB00108
@en
elimination half-life
KEGG
D06886
@en
legal EU
Rx-only
@en
legal status
Rx-only
@en
legal UK
POM
@en
legal US
Rx-only
@en
licence EU
yes
@en
licence US
Natalizumab
@en
mab type
mab
@en
MedlinePlus
a605006
@en
molecular weight
pregnancy AU
C
@en
pregnancy US
N
@en
routes of administration
source
zu/o
@en
synonyms
AN100226M
@en
target
alpha-4 integrin
@en
tradename
Tysabri, Antegren, others
@en
type
mab
@en
Verifiedfields
changed
@en
verifiedrevid
458,283,255
Watchedfields
changed
@en
wikiPageUsesTemplate
hypernym
comment
Le natalizumab est un anticorp ...... atteints de maladie de Crohn.
@fr
Natalizumab (Handelsname Tysab ...... ehört zu den IgG4-Antikörpern.
@de
Natalizumab (commercializzato ...... o in Italia nel dicembre 2006.
@it
Natalizumab (preparaty handlow ...... ożylnym w gabinecie lekarskim.
@pl
Natalizumab es un inhibidor se ...... e la esclerosis múltiple (EM).
@es
Natalizumab is een middel voor ...... ri® en de fabrikant is Biogen.
@nl
Natalizumab je humanizovaná mo ...... í relapsům u Crohnovy choroby.
@cs
Natalizumab é um fármaco utilizado no tratamento da esclerose múltipla.
@pt
Tysabri är ett läkemedel som a ...... ger minskade mängd nervskador.
@sv
Натализумаб (англ. natalizumab ...... ине его высокой эффективности.
@ru